A machine learning model was more effective at detecting congenital long QT syndrome on resting ECGs than manual measurement of QT intervals by arrhythmia experts, in a new study. Researchers ...

Leuven, Belgium - Physicians in Belgium are warning colleagues about a misdiagnosis they say may be relatively common, particularly among young patients, but easily prevented with electrophysiological ...

LQT-1213 is a first-in-class serum glucocorticoid regulated kinase 1 inhibitor. The Food and Drug Administration (FDA) has granted Orphan Drug designation to LQT-1213, a first-in-class serum ...

QT延長症候群（Long-QT Syndrome）の治療にはβ遮断薬が広く使われているが、投与中の心停止や突然死の報告もある。しかしそれらの心イベントがβ遮断薬による治療の失敗を示すものなのか、別の要因によるものなのかは明らかではない。近年では、β遮断薬を ...

Please provide your email address to receive an email when new articles are posted on . In long QT syndrome, patients doing vigorous exercise did not have more events than those doing nonvigorous ...

MONTREAL, Sept. 17, 2025 /CNW/ - Thryv Therapeutics Inc., a clinical-stage biotechnology company pioneering novel serum glucocorticoid inducible kinase 1 (SGK1) inhibitors for cardiovascular diseases, ...

Wave II clinical study will evaluate THRV-1268, Thryv's oral SGK1 inhibitor, in adults with Long QT Syndrome Type 2. Wave II is informed by the successful Wave I clinical study with LQT-1213 and ...

Dublin, Sept. 27, 2024 (GLOBE NEWSWIRE) -- The "Long QT Syndrome (LQTS) Market Assessment: Epidemiology, Treatment Landscape, Unmet Needs, Emerging Therapies, and Value & Access" report has been added ...

FRESNO, Calif. (KFSN) -- The discovery of a heart condition in young people used to mean "benching" from them sports for good. But doctors have found a way to keep kids in the game, despite their ...

In many low- and middle-income countries, pediatric cardiologists can't help children with congenital heart conditions because of a critical hurdle. They don't have easy access to advanced diagnostic ...